Incentives for Global Public Health
Patent Law and Access to Essential Medicines
$133.00
Part of Connecting International Law with Public Law
- Editors:
- Thomas Pogge, Yale University, Connecticut
- Matthew Rimmer, Australian National University, Canberra
- Kim Rubenstein, Australian National University, Canberra
- Date Published: July 2010
- availability: In stock
- format: Hardback
- isbn: 9780521116565
$133.00
Hardback
Other available formats:
Paperback, eBook
Looking for an examination copy?
If you are interested in the title for your course we can consider offering an examination copy. To register your interest please contact collegesales@cambridge.org providing details of the course you are teaching.
-
This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.
Read more- Connects international and public law, extending each discipline's understanding of the other
- Explores institutional mechanisms that would create additional incentives to develop essential medicines while also ensuring real access to the new products even for the world's poorest populations
- Provides policy impetus to those working in the area of global health
Customer reviews
17th Nov 2013 by Kavin
This is a well edited collection from leading international scholars on the subject of global health, one that provides comprehensive analysis on the role of innovation in promoting health. Although the literature on this subject is vast, this volume presents new and challenging insights. Short, focussed chapters cover a good breadth of topics and shed fresh and clear light on the public side of the debate on access to essential medicines.
Review was not posted due to profanity
×Product details
- Date Published: July 2010
- format: Hardback
- isbn: 9780521116565
- length: 536 pages
- dimensions: 235 x 158 x 29 mm
- weight: 0.98kg
- availability: In stock
Table of Contents
Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein
Part I. International Trade:
1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss
2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon
3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu
4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng
Part II. Innovation:
5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge
6. The Health Impact Fund: a critique Kathleen Liddell
7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed
8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce
Part III. Intellectual Property:
9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen
10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas
11. Accessing and benefit sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking
12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer
Part IV. Health-Care:
13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky
14. Securing health through rights Katharine Young
15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra
16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod.
Related Books
related journals
You are now leaving the Cambridge University Press website, your eBook purchase and download will be completed by our partner www.ebooks.com. Please see the permission section of the www.ebooks.com catalogue page for details of the print & copy limits on our eBooks.
Continue ×